Biovision

BioVision, Inc. is a U.S.-based biotechnology company headquartered in Milpitas, California. Founded in 1999, BioVision specializes in developing and supplying a wide range of life science research tools, including biochemical and cell-based assay kits, recombinant proteins, antibodies, enzymes, and biochemical compounds. Their products support research, diagnostics, and drug discovery across various fields such as oncology, immunology, neuroscience, and metabolism.

Core Offerings

1. Assay Kits

BioVision offers a diverse portfolio of assay kits designed for sensitive and quantitative detection of various biomolecules:

• cAMP Direct Immunoassay Kit (Colorimetric): A direct competitive immunoassay for determining cAMP levels in biological samples.
• Lactate Colorimetric Assay Kit II: Designed for measuring lactate levels in mammalian samples, including cell and tissue culture supernatants, urine, and plasma.
• Adipogenesis Assay Kit: Allows for rapid and sensitive measurement of adipogenesis in various samples.
• Annexin V-FITC Apoptosis Kit: A one-step staining procedure for detecting apoptotic cells, suitable for flow cytometry or fluorescence microscopy.

2. Recombinant Proteins and Enzymes

BioVision provides a wide range of recombinant proteins and enzymes, including cytokines, growth factors, and metabolic enzymes, to support various research applications.

3. Antibodies

The company offers a comprehensive selection of monoclonal and polyclonal antibodies targeting various antigens, including cell surface markers, intracellular proteins, and signaling molecules.

4. ELISA Kits

BioVision develops and manufactures highly sensitive and specific ELISA kits for the detection of various biomarkers, including cytokines, hormones, and metabolic products.